Adverse events after pleurodesis in patients with malignant pleural effusion.

ABSTRACT:

Background

Malignant pleural effusion (MPE) is an important sign of advanced disease in metastatic cancer. Pleurodesis is one option to treat recurrent MPE. The Inflammatory response after pleurodesis may lead to important adverse events (AE) in a set of very ill patients.

Methods

Retrospective analysis of patients submitted to pleurodesis (2009-2013). Clinical and laboratory data were collected. We compare the values in the day of pleurodesis, 2^nd, 5^th and 10^th days after.

Results

One hundred fourteen patients were undergone to pleurodesis with silver nitrate (46%), iodine (52%) and talc (2%). Female was the most frequent (86%) and the breast cancer was the most common primary site. The most frequent adverse event was low hemoglobin a

SUBMITTER: Terra RM 

PROVIDER: S-EPMC7399432 | biostudies-literature | 2020 Jul

REPOSITORIES: biostudies-literature